Company · CIK 1826492

# Gracell Biotechnologies Inc.

| CIK | [1826492](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001826492) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | China |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-04-23 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-264545 | Shelf Effective | 2022-04-28 | 2024-02-27 | 3 |
| 333-274191 | Shelf Effective | 2023-08-24 | 2024-02-27 | 3 |
| 333-251494 | IPO Final prospectus | 2020-12-18 | 2021-01-08 | 6 |

## Filings

 14

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2024-02-27 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1826492/999999999524000558/9999999995-24-000558-index.htm) Declared effective | 333-274191 | 9999999995-24-000558 |
| 2024-02-27 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1826492/999999999524000552/9999999995-24-000552-index.htm) Declared effective | 333-264545 | 9999999995-24-000552 |
| 2023-09-25 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1826492/999999999523002738/9999999995-23-002738-index.htm) Declared effective | 333-274191 | 9999999995-23-002738 |
| 2023-08-24 | [F-3](https://www.sec.gov/Archives/edgar/data/1826492/000110465923094883/0001104659-23-094883-index.htm) Shelf registered | 333-274191 | 0001104659-23-094883 |
| 2022-06-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1826492/999999999522001936/9999999995-22-001936-index.htm) Declared effective | 333-264545 | 9999999995-22-001936 |
| 2022-04-28 | [F-3](https://www.sec.gov/Archives/edgar/data/1826492/000119312522127897/0001193125-22-127897-index.htm) Shelf registered | 333-264545 | 0001193125-22-127897 |
| 2021-01-08 | [424B4](https://www.sec.gov/Archives/edgar/data/1826492/000119312521005025/0001193125-21-005025-index.htm) Final prospectus | 333-251494 | 0001193125-21-005025 |
| 2021-01-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1826492/999999999521000086/9999999995-21-000086-index.htm) Declared effective | 333-251864 | 9999999995-21-000086 |
| 2021-01-07 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1826492/999999999521000069/9999999995-21-000069-index.htm) Declared effective | 333-251494 | 9999999995-21-000069 |
| 2021-01-07 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1826492/000119312521003677/0001193125-21-003677-index.htm) Amendment | 333-251494 | 0001193125-21-003677 |
| 2021-01-06 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1826492/000119312521003131/0001193125-21-003131-index.htm) Amendment | 333-251494 | 0001193125-21-003131 |
| 2021-01-04 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1826492/000119312521000413/0001193125-21-000413-index.htm) Amendment | 333-251494 | 0001193125-21-000413 |
| 2020-12-18 | [F-1](https://www.sec.gov/Archives/edgar/data/1826492/000119312520321500/0001193125-20-321500-index.htm) Registration filed | 333-251494 | 0001193125-20-321500 |
| 2020-10-19 | [DRS](https://www.sec.gov/Archives/edgar/data/1826492/000095012320010314/0000950123-20-010314-index.htm) Draft made public | 377-03682 | 0000950123-20-010314 |

[All filings of this company](https://equitycapital.markets/filings?cik=1826492) · [CSV](https://equitycapital.markets/filings.csv?cik=1826492)

---
Source page: https://equitycapital.markets/company/1826492 · Data: U.S. SEC EDGAR · CC BY 4.0